The genotoxic and oxidative damage potential of olanzapine in vitro

Hasan Türkez1, Başak Toğar

  • 1Biology Department, Science Faculty, Atatürk University, Erzurum, Turkey.

Insights

Olanzapine (OLZ) did not cause DNA damage in human lymphocytes. However, high doses of this antipsychotic drug induced oxidative stress, suggesting potential tissue damage.

Area of Science:

  • Pharmacology
  • Toxicology
  • Genetics

Background:

  • Olanzapine (OLZ) is an atypical antipsychotic used for schizophrenia and bipolar disorder.
  • Concerns exist regarding OLZ's potential cytotoxic effects on nervous and immune systems.
  • Limited data exists on OLZ's genotoxic and oxidative damage potential in human lymphocytes.

Purpose of the Study:

  • To evaluate the genotoxic potential of OLZ in human whole blood cultures (WBCs).
  • To assess the impact of OLZ on oxidative status, including total antioxidant capacity (TAC) and total oxidative stress (TOS).

Main Methods:

  • Human whole blood cultures were treated with varying concentrations of OLZ (0 to 160 µM).
  • Genotoxicity was assessed using the sister-chromatid exchange (SCE) test.
  • Oxidative stress markers (TAC and TOS) were measured biochemically.

Main Results:

  • Olanzapine did not induce sister-chromatid exchanges (SCEs), indicating no genotoxic effect on lymphocytes.
  • The highest concentration of OLZ applied resulted in significant oxidative stress.
  • A dose-dependent increase in oxidative stress markers was observed with OLZ treatment.

Conclusions:

  • Olanzapine demonstrates a lack of genotoxicity in human lymphocyte cultures.
  • High concentrations of OLZ can induce oxidative stress, potentially leading to tissue damage.
  • While generally safe, clinical use of OLZ requires consideration of its oxidative stress-inducing properties.